- Home
- KRYS vs MRP Comparison
KRYS vs MRP Comparison
Compare KRYS & MRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- MRP
- Stock Information
- Founded
- KRYS 2015
- MRP N/A
- Country
- KRYS United States
- MRP United States
- Employees
- KRYS N/A
- MRP N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- MRP
- Sector
- KRYS Health Care
- MRP
- Exchange
- KRYS Nasdaq
- MRP NYSE
- Market Cap
- KRYS 3.8B
- MRP 4.1B
- IPO Year
- KRYS 2017
- MRP N/A
- Fundamental
- Price
- KRYS $143.08
- MRP $28.03
- Analyst Decision
- KRYS Strong Buy
- MRP Strong Buy
- Analyst Count
- KRYS 9
- MRP 2
- Target Price
- KRYS $208.78
- MRP $30.75
- AVG Volume (30 Days)
- KRYS 374.0K
- MRP 1.0M
- Earning Date
- KRYS 08-04-2025
- MRP 08-18-2025
- Dividend Yield
- KRYS N/A
- MRP 9.28%
- EPS Growth
- KRYS 109.01
- MRP N/A
- EPS
- KRYS 4.16
- MRP N/A
- Revenue
- KRYS $333,448,000.00
- MRP $82,698,000.00
- Revenue This Year
- KRYS $44.05
- MRP N/A
- Revenue Next Year
- KRYS $46.15
- MRP N/A
- P/E Ratio
- KRYS $34.43
- MRP N/A
- Revenue Growth
- KRYS 247.53
- MRP N/A
- 52 Week Low
- KRYS $122.80
- MRP $21.02
- 52 Week High
- KRYS $219.34
- MRP $28.99
- Technical
- Relative Strength Index (RSI)
- KRYS 57.50
- MRP N/A
- Support Level
- KRYS $135.86
- MRP N/A
- Resistance Level
- KRYS $143.44
- MRP N/A
- Average True Range (ATR)
- KRYS 5.15
- MRP 0.00
- MACD
- KRYS 1.07
- MRP 0.00
- Stochastic Oscillator
- KRYS 80.33
- MRP 0.00
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About MRP MILLROSE PROPERTIES INC.
Millrose Properties Inc is a Holding Company. The company along with its subsidiaries engages in providing operational and capital solutions for home builders and land development companies to finance the acquisition and development of land assets through its Homesite Option Purchase Platform.